1. Letter to the Editor: Interobserver Variability of Heart-to-Mediastinum Ratio in I-123 MIBG Sympathetic Imaging

   • Ben F. Bulten
   • Roel L. F. van der Palen
   • Lioe-Fee de Geus-Oei

   Letter to the Editor Open access 09 May 2012 Pages: 389 - 390

2. Reply to the letter by Ben F. Bulten et al. regarding “Interobserver Variability of Heart-to-Mediastinum Ratio in I-123 MIBG Sympathetic Imaging”

   • Wengen Chen
   • Qi Cao
   • Vasken Dilsizian

   Letter to the Editor 05 May 2012 Pages: 391 - 391

3. Can Bridge to Recovery Help to Reveal the Secrets of the Failing Heart?

   • Michael Ibrahim
   • Cesare Terracciano
   • Magdi H. Yacoub

   Invited Commentary 18 May 2012 Pages: 392 - 396

   

4. Initial Strategy of Revascularization Versus Optimal Medical Therapy for Improving Outcomes in Ischemic Heart Disease: A Review of the Literature

   • A. Vincent Songco
   • Sorin J. Brener

   Ischemic Heart Disease (S Brener, Section Editor) 04 May 2012 Pages: 397 - 407

   

5. Late Stent Thrombosis: The Last Remaining Obstacle in Coronary Interventional Therapy

   • Piera Capranzano
   • George Dangas

   Ischemic Heart Disease (S Brener, Section Editor) 03 July 2012 Pages: 408 - 417

6. Preservation of Myocardium During Coronary Artery Bypass Surgery

   • Takeshi Kinoshita
   • Tohru Asai

   Ischemic Heart Disease (S Brener, Section Editor) 18 April 2012 Pages: 418 - 423

7. Periprocedural Myocardial Enzyme Elevation: Prognostic Implications for Current Practice

   • Sanjum S. Sethi
   • Avtar Singh
   • Michael E. Farkouh

   Ischemic Heart Disease (S Brener, Section Editor) 07 June 2012 Pages: 424 - 432

   

8. Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Atherosclerosis Prevention

   • Maria M. Patarroyo Aponte
   • Gary S. Francis

   Ischemic Heart Disease (S Brener, Section Editor) 05 May 2012 Pages: 433 - 442

   

9. Regression of Atherosclerosis

   • Benoit J. Arsenault
   • Ekaterini A. Kritikou
   • Jean-Claude Tardif

   Ischemic Heart Disease (S Brener, Section Editor) 17 June 2012 Pages: 443 - 449

10. New Anticoagulants in Ischemic Heart Disease

    • Lawrence Rajan
    • David J. Moliterno

    Ischemic Heart Disease (S Brener, Section Editor) 22 April 2012 Pages: 450 - 456

11. Platelet Function and Inhibition in Ischemic Heart Disease

    • Annunziata Nusca
    • Giuseppe Patti

    Ischemic Heart Disease (S Brener, Section Editor) 05 May 2012 Pages: 457 - 467

    

12. Revascularization for Left Main and Multivessel Coronary Artery Disease in the Drug-Eluting Stent Era: Integration of Recent Drug-Eluting Stent Trials

    • Samip Vasaiwala
    • David O. Williams

    Ischemic Heart Disease (S Brener, Section Editor) 26 May 2012 Pages: 468 - 476

13. Coronary Stent Choice in Patients with Acute Myocardial Infarction

    • Giulio G. Stefanini
    • Stephan Windecker

    Management of Acute Coronary Syndromes (R Mehran, Section Editor) 13 May 2012 Pages: 477 - 485

    

14. Which Antiplatelet Agent for Whom? Which Patient Populations Benefit Most from Novel Antiplatelet Agents (Ticagrelor, Prasugrel)?

    • Christoph Varenhorst
    • Stefan James

    Management of Acute Coronary Syndromes (R Mehran, Section Editor) 26 April 2012 Pages: 486 - 492

15. Which Antithrombin for Whom? Identifying the Patient Population that Benefits Most from Novel Antithrombin Agents

    • David A. Burke
    • Haider J. Warraich
    • Duane S. Pinto

    Management of Acute Coronary Syndromes (R Mehran, Section Editor) 03 June 2012 Pages: 493 - 501

    

16. Radial Versus Femoral Access for Percutaneous Coronary Intervention: Implications for Vascular Complications and Bleeding

    • Sandeep Nathan
    • Sunil V. Rao

    Management of Acute Coronary Syndromes (R Mehran, Section Editor) 26 June 2012 Pages: 502 - 509

17. Risk Stratification and Timing of Revascularization: Which Patients Benefit from Early Versus Later Revascularization?

    • Ian J. Sarembock
    • Dean J. Kereiakes

    Management of Acute Coronary Syndromes (R Mehran, Section Editor) 13 May 2012 Pages: 510 - 520

    

18. Is There Attenuation of Benefit of Invasive Therapy in Patients with Chronic Kidney Disease? Results from Randomized Trials and Registry Data

    • Jennifer Yu
    • Sze-Yuan Ooi
    • Usman Baber

    Management of Acute Coronary Syndromes (R Mehran, Section Editor) 26 May 2012 Pages: 521 - 527

19. Multivessel Versus Culprit-Only Revascularization: One Time Versus Staged Procedures for the ACS Population

    • Pablo Codner
    • Ran Kornowski

    Management of Acute Coronary Syndromes (R Mehran, Section Editor) 25 April 2012 Pages: 528 - 536